Justin Strickland, MD
Orthopaedic Surgery · Wichita, KSNPI 1891766531
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (49.2%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Arthrex at 49.4% of the total. Reporting peaked in 2021 at $13,283 and has fallen 89.4% since, to $1,411 in 2025.
Across 96 payments — averaging $270.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$13K
- Medacta USA, Inc.$11K
- Titan Surgical Group, LLC$767
- Ferring Pharmaceuticals Inc.$349
- Smith+Nephew$284
- Pacira Therapeutics, Inc.$126
- plus $461 from 11 others
What the payments were for
- Consulting fees$2811%
- Speaking & faculty fees$10,88742%
- Travel & lodging$12,78649%
- Food & beverage$2,0318%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 21 | $12,828 |
| Medacta USA, Inc. | 17 | $11,169 |
| Titan Surgical Group, LLC | 4 | $767 |
| Ferring Pharmaceuticals Inc. | 21 | $349 |
| Smith+Nephew | 8 | $284 |
| Pacira Therapeutics, Inc. | 7 | $126 |
| Miach Orthopaedics, Inc. | 1 | $122 |
| Johnson & Johnson | 2 | $63 |
| Vertex | 2 | $59 |
| Vericel Corporation | 3 | $54 |
| Bioventus LLC | 2 | $32 |
| Medtronic(2 entities) | 2 | $30 |
| Fidia Pharma USA Inc. | 2 | $30 |
| Stryker | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| AbbVie | 1 | $14 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,985 in reported general payments places this provider in the 85th percentile of 197 orthopaedic surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 13 | $113 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Wichita
- Tyler BronWichita$107K
- Jeffrey ShepherdWichita$87K
- Scott AdrianWichita$58K
- Andrew MerwinWichita$45K
- Paul EnnsWichita$27K
- Levi KindelWichita$10K
- Scott HaskinsWichita$9K
- Kevin HoferWichita$9K
- David AndersonKansas City$490K
- Brandon CarlsonKansas City$299K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.